Cargando…

Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer

PURPOSE: To assess the influence of age as a continuous variable on the prognosis of pT1-2N1 breast cancer and examine its decision-making value for postmastectomy radiotherapy (PMRT). METHODS: We retrospectively evaluated 5438 patients with pT1-2N1 breast cancer after mastectomy in 11 hospitals. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xu-Ran, Tang, Yu, Wu, Hong-Fen, Guo, Qi-Shuai, Zhang, Yu-Jing, Shi, Mei, Cheng, Jing, Wang, Hong-Mei, Liu, Min, Ma, Chang-Ying, Wen, Ge, Wang, Xiao-hu, Fang, Hui, Jing, Hao, Song, Yong-Wen, Jin, Jing, Liu, Yue-Ping, Chen, Bo, Qi, Shu-Nan, Li, Ning, Tang, Yuan, Lu, Ning-Ning, Zhang, Na, Li, Ye-Xiong, Wang, Shu-Lian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587343/
https://www.ncbi.nlm.nih.gov/pubmed/36270084
http://dx.doi.org/10.1016/j.breast.2022.08.005
Descripción
Sumario:PURPOSE: To assess the influence of age as a continuous variable on the prognosis of pT1-2N1 breast cancer and examine its decision-making value for postmastectomy radiotherapy (PMRT). METHODS: We retrospectively evaluated 5438 patients with pT1-2N1 breast cancer after mastectomy in 11 hospitals. A multivariable Cox proportional hazards regression model with penalized splines was used to examine the relationship between age and oncologic outcomes. RESULTS: The median follow-up was 67.0 months. After adjustments for confounding characteristics, nonsignificant downward trend in locoregional recurrence (LRR) risk was observed with increasing age (P-non-linear association = 0.640; P-linear association = 0.078). A significant non-linear association was found between age and disease-free survival (DFS) and overall survival (OS) (P-non-linear association <0.05; P-linear association >0.05, respectively). The DFS and OS exhibited U-shaped relationships, with the hazard ratios (HRs), reaching a nadir at 50 years old. A decreased risk of LRR with PMRT vs. no PMRT (HR = 0.304, 95% CI: 0.204–0.454) was maintained in all ages. The HR of PMRT vs. no PMRT for DFS and OS gradually increased with age. In patients ≤50 years old, PMRT was independently associated with favorable LRR, DFS, and OS, all P < 0.05). In patients >50 years old, PMRT was independently associated with reduced LRR (P = 0.004), but had no effect on DFS or OS. CONCLUSIONS: Age was an independent prognostic factor for pT1-2N1 breast cancer; PMRT provided survival benefits for patients ≤50 years old, but not for patients >50 years old.